Vanguard High Dividend Yield ETF
Latest Vanguard High Dividend Yield ETF News and Updates
What Does BP’s Short Interest Analysis Reveal?
Short interest in BP (BP), which has been rising since the beginning of 2016, has witnessed a 23% fall since July 14, 2016.
Must-know: Dividends as a hedge against stock market bubbles
Dividends pay returns even during market recovery. Major market indices like the S&P 500 (SPY), Dow Jones (DIA) and NASDAQ (QQQ) can be seen surging to record highs during a bubble.
Why investors prefer dividends in a low interest rate environment
The Fed’s policy of keeping the nominal interest rates at a zero lower bound leads some investors to seek higher and stabler income elsewhere. The low-interest rate regime may force risk-taking investors towards the higher-cost debt of high yield bonds.
What Is Chevron’s Cash Flow Strategy?
In the first nine months of 2016, CVX’s cash flow from operations stood at $8.9 billion, falling from $14.9 billion in the first nine months of 2015.
Why General Electric Sold Its Appliances Business to Haier
General Electric wants to shift away from the appliances business, as this segment doesn’t fit into its core business portfolio.
A Look at Analysts’ Top 5 US Steel Stocks
In this overview article, we’ll see how analysts are rating the leading steel stocks, and we’ll also compare performance from the top five steel companies.
Extra Space Storage: What’s Driving the Dividend and Valuations?
In the first quarter, Extra Space Storage’s (EXR) revenue grew 9%, driven by property rental, tenant reinsurance, and management fees.
Johnson & Johnson Advances in Robotics Surgery with Orthotaxy
On February 20, Johnson & Johnson (JNJ) announced the acquisition of Orthotaxy to develop its robot-assisted orthopedics surgery platform.
Opdivo Could Be Long-Term Growth Driver for Bristol-Myers Squibb
In 1Q17, 2Q17, and 3Q17, Opdivo reported revenues of $1.1 billion, $1.2 billion, and $1.3 billion, respectively.
These Factors Are Contributing to Gilead Sciences’ Weak Outlook
Gilead Sciences’ (GILD) revenue fell 7% and 13% in 2016 and 9M17, respectively. The fall was due to lower product sales. Both antiviral products and other products recorded declines in both the periods.
How Increasing Biologic Penetration Could Boost AbbVie’s Revenues
AbbVie (ABBV) is currently focused on advancing the research programs for its late-stage immunology assets, Upadacitinib and Risankizumab.
How Does GOOGL Compare to Broad Indexes?
Alphabet’s (GOOGL) revenue rose 20% and 22% in 2016 and 9M17 (the first nine months of 2017), respectively.
How Has Eli Lilly’s Cyramza Performed
In 3Q17, Eli Lilly’s (LLY) Cyramza generated revenues of $196 million, which reflected ~23% growth on a YoY basis and 5% growth on a quarter-over-quarter basis.
How the Dividend Cut Affected KMI’s Dividend Yield
Kinder Morgan’s (KMI) costs and expenses rose 2.0% in 2015 before falling 21.0% in 2016.
Why the Dividend Yield of Microsoft Has Taken a Downturn
Microsoft’s (MSFT) 5.0% revenue growth in 2017 has been mainly driven by productivity and business processes and intelligent cloud, offset by more personal computing and other segments.
Frontier Communications: High Dividend Yield despite Dividend Cut
In this series, we’ll look some small-cap stocks with high dividend yields.
Dividend Yield of Air Products & Chemicals
In this series, we’ll be looking at ten dividend aristocrats with low PE ratios. Dividend aristocrats are S&P 500 stocks that have raised their dividend payouts for at least 25 successive years.
A Brief Look at Dividend Aristocrats
The S&P 500 Dividend Aristocrat Index is made up of 51 S&P 500 (SPY) (SPX-INDEX) companies that have increased their dividends for 25 successive years.
Analyzing the Dividend Curves of General Electric and Cisco Systems
General Electric’s (GE) revenue fell 7.0% in the first half of 2017, driven by its energy connections and lighting business.
A Look a the Top Twenty Dividend Growers over the Last 25 Years
This series will discuss how these stocks have been able to achieve continuous dividend growth.
Nplate and Vectibix Could Contribute to Amgen’s Revenue Growth in 2017
In 1Q17, Amgen’s (AMGN) Nplate generated revenues of ~$154 million, which reflected a year-over-year growth rate of 9%.
General Electric Is Eyeing a Big Slice of the Software Pie
On January 10, 2017, General Electric (GE) completed its acquisition of ServiceMax, a leader in cloud-based field service management solutions, for $915.0 million.
Zepatier Should Boost Merck’s Profit Margins in the Future
On January 28, Merck’s Zepatier secured approval from the FDA as a therapy for adult patients suffering from genotype 1 or genotype 4 HCV (Hepatitis C).
Bernstein: Excess Risk Aversion Has Made Investors ‘Wallflowers’
In his November Insights newsletter, Richard Bernstein stated, “It is incredible that investors have basically been wallflowers during the second longest bull market of the post-war period.”
Why Is Domtar Planning to Use Fluff Pulp in Manufacturing?
Price movement Domtar (UFS) has a market cap of $2.3 billion. It fell 1.4% to close at $36.97 per share on September 23, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were 4.5%, -1.2%, and 2.3%, respectively, on the same day. UFS is trading 0.49% above its 20-day moving average, 0.73% below […]
Domtar Acquires Home Delivery Incontinent Supplies
Domtar has a market cap of $2.5 billion. It rose by 0.60% and closed at $38.45 per share on August 18. It reported 2Q16 consolidated sales of $1.27 billion.
How Did Petrobras’s Stock Perform on Its Earnings Day?
Petrobras announced its earnings on August 11, 2016, after the Market closed. On that day, PBR’s stock opened at $8.47 per share.
Domtar Declares a Dividend of $0.42 Per Share
Domtar (UFS) fell by 0.38% to close at $39.22 per share during the first week of August 2016.
How Shell’s Stock Performed after Its 2Q16 Earnings Release
Royal Dutch Shell (RDS.A) announced lower-than-expected earnings on July 28, 2016, before the markets opened.
How Did Domtar Perform in 2Q16?
Domtar (UFS) has a market cap of $2.5 billion. It rose by 11.9% to close at $39.53 per share on July 27, 2016.
Chevron’s Leverage Position: Comfy or Cramped?
Chevron’s net debt-to-adjusted EBITDA stood at 1.4x in 4Q15. This is higher than the average ratio of 1.1x of Exxon Mobil, BP, and Royal Dutch Shell.
US Steel Demand Indicators Have Been Mixed
Looking at steel demand indicators, we see that construction activity has generally been strong in 2015, with spending in the United States exceeding $1 trillion for seven consecutive months.
What Factors Drove Nucor’s 3Q15 Earnings?
Nucor’s capacity utilization rate fell to a dismal 69% in 3Q15. Nucor had a healthy utilization rate of 81% in 3Q14.
Is Nucor Creating a War Chest for Acquisitions?
Nucor had a debt-to-capital ratio of 36% as of September 30, 2015. The company closed the quarter with cash and marketable securities of ~$2 billion.
Must-know: 3 key risks in stock market investing
Know the market and know your own appetite for risk before investing. You can’t eliminate market risk, also called systematic risk, through diversification. You can, however, hedge against market risk.
